filmov
tv
Dr. Mamounas on Extended Letrozole Therapy for Breast Cancer
Показать описание
Terry P. Mamounas, MD, medical director of the Comprehensive Breast Program at the University of Florida Health Cancer Center, discusses the phase III trial for extended letrozole (Femara) therapy for breast cancer patients.
0:01:22
Dr. Mamounas on Extended Letrozole Therapy for Breast Cancer
0:18:29
Mamounas EP, Bandos H, Lembersky BC, Geyer CE, et al.:
0:01:04
Dr. Mamounas on Adjuvant Endocrine Therapy for Breast Cancer
0:01:16
Dr. Terry Mamounas on the Results from NSABP B-28 Study and Oncotype DX - 2012 SABCS
0:07:49
Five years of letrozole doesn't improve disease free survival for HR positive breast cancer
0:01:05
Dr. Blok on Results of Adjuvant Letrozole Study in Breast Cancer
0:06:23
Matched mutations and long term letrozole for breast cancer
1:10:36
Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice Guideli...
0:00:47
Breast cancer prognosis explained
0:00:39
What is breast cancer prognosis?
0:01:09
Dr. Becerra on Ribociclib/Letrozole in ER+/HER2- Breast Cancer
0:00:06
3 Ways to be Joint Pain Free
0:00:55
Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast Cancer
0:01:24
Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast Cancer
0:16:19
Breast Cancer Index, Extended Endocrine Therapy | Elizabeth Ott, PA | 2022 West Oncology APP Updates
0:02:31
Using Aromatase Inhibitors Longer Than 5 Years
0:06:15
Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, et alt.
0:22:14
Adjuvant endocrine therapy in postmenopausal women: Risk stratification, type & duration
0:01:55
Extending Estrogen-Blocking Tamoxifen Therapy for Breast Cancer Patients -- Sloan-Kettering
0:01:26
RIBECCA: ribociclib, a CDK4/6 inhibitor in ER+ breast cancer
0:20:25
HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy
0:03:27
Who gets Breast Cancer Recurrences? - with Dr Tasha
0:38:22
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit
0:02:33
Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer
Комментарии